A–D) Expression of DN-GSK3β in the central nervous system prevents zDisc1 loss of function defects. A) Experimental design. B) Effects of DN-GSK3β in the CNS. a–b) F0 Tg(miR124:IresGFP) + CMO (88% normal, n=31). c–d) F0 Tg(miR124:DN-GSK3β-IresGFP) + CMO (70% normal, n=30). e–f) F0 Tg(miR124:IresGFP) + Disc1MO (0% normal, n=32). g–h) F0 Tg(miR124:DN-GSK3β-IresGFP) + Disc1MO (82% normal, n=32). a, c, e, g) Lateral view of whole embryo. a′, c′, e′, g′) Lateral view of muscle segments. b, d, f, h) Dorsal view of head after ventricle injection. C) Effects of DN-GSK3β in CNS on hindbrain axons. Embryos assayed at 36 hpf in 2 independent experiments, and immunostained for acetylated tubulin. a, b) F0 Tg(miR124:IresGFP) + CMO (100% normal, n=10). c, d) F0 Tg(miR124:DN-GSK3β-IresGFP) + CMO (100% normal, n=10). e, f) F0 Tg(miR124:IresGFP) + Disc1MO (0% normal, n=10). g, h) F0 Tg(miR124:DN-GSK3β-IresGFP) + Disc1MO (90% normal, n=10). a, c, e, g) Lateral view of head neurons. b, d, f, h) Dorsal view of hindbrain neurons. D) Effects of DN-GSK3β in CNS on muscle segments. Embryos immunostained for phalloidin at 30 hpf in 2 independent experiments. a) F0 Tg(miR124:IresGFP) + CMO (100% normal, n=10). b) F0 Tg(miR124:DN-GSK3β-IresGFP) + CMO (100% normal, n=10). c) F0 Tg(miR124:IresGFP) + Disc1MO (0% normal, n=10). d) F0 Tg(miR124:DN-GSK3β-IresGFP) + Disc1MO (80% normal, n=10). Lateral view of somites, anterior to the left. Dotted lines: muscle segment shape. E–H) Expression of DN-GSK3β in mesendoderm prevents muscle segment defects after zDisc1 loss of function. E) Experimental design. F) Effects of DN-GSK3β in the mesendoderm. a–b) F0 Tg(Ntl:IresGFP) + CMO (85% normal, n=34). c–d) F0 Tg(Ntl:DN-GSK3β-IresGFP) + CMO (75% normal, n=32). e–f) F0 Tg(miR124:IresGFP) + Disc1MO (0% normal, n=30). g–h) F0 Tg(miR124:DN-GSK3β-IresGFP) + Disc1MO (84% normal, n=32). a, c, e, g) Lateral view of whole embryo. a′, c′, e′, g′) Lateral view of the muscle segments. b, d, f, h) Dorsal view of head. G) Effects of DN-GSK3β in mesendoderm on muscle segments. Embryos were immunostained for phalloidin at 30 hpf in 2 independent experiments. a) F0 Tg(Ntl:IresGFP) + CMO (100% normal, n=10). b) F0 Tg(Ntl:DN-GSK3β-IresGFP) + CMO (100% normal, n=10). c) F0 Tg(Ntl:IresGFP) + Disc1MO (0% normal, n=12). d) F0 Tg(Ntl:DN-GSK3β-IresGFP) + Disc1MO (83% normal, n=12). Lateral view of muscle segments, anterior to left. Dotted lines: muscle segment shape. H) Effects of DN-GSK3β in mesendoderm on hindbrain axons. Embryos assayed at 36 hpf in 2 independent experiments, and immunostained for acetylated tubulin. a, b) F0 Tg(Ntl:IresGFP) embryos + CMO (100% normal, n=11). c, d) F0 Tg(Ntl:DN-GSK3β-IresGFP) + CMO (100% normal, n=9). e, f) F0 Tg(Ntl:IresGFP) + Disc1MO (0% normal, n=11). (g, h) F0 Tg(Ntl:DN-GSK3β-IresGFP) + Disc1MO (2% normal, n=12). a, c, e, g) Lateral view of head neurons. b, d, f, h) Dorsal view of hindbrain neurons. I) Schematic of Disc1interaction with the β-catenin-mediated and noncanonical Wnt pathways. ac, anterior commissure; poc, postoptic commissure; sot, supraoptic tract; tpc, tract of posterior commissure; r, rhombomeres.